Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A randomized, multicenter, phase IIIb open-label study to evaluate the efficacy of sequential therapy of PeginterferOn alfa-2a (PegasysⓇ) following ENTecavir compared with Peginterferon alfa-2a monotherapy in patients with HBeAg positive chronic hepatitis B: Interim analysis of POTENT study
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 손주현 | - |
| dc.date.accessioned | 2021-08-03T13:35:34Z | - |
| dc.date.available | 2021-08-03T13:35:34Z | - |
| dc.date.issued | 2012-11-12 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/49513 | - |
| dc.title | A randomized, multicenter, phase IIIb open-label study to evaluate the efficacy of sequential therapy of PeginterferOn alfa-2a (PegasysⓇ) following ENTecavir compared with Peginterferon alfa-2a monotherapy in patients with HBeAg positive chronic hepatitis B: Interim analysis of POTENT study | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | the Liver Meeting” (63th AASLD meeting) | - |
| dc.citation.conferencePlace | 미국 보스톤 | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.